Cargando…

The effectiveness and safety of pertussis booster vaccination for adolescents and adults: A systematic review and meta-analysis

BACKGROUND: Due to the resurgence of pertussis, many countries have revised the pertussis immunization schedules and recommended booster doses of pertussis component vaccine for adolescents and adults. Here we aim to investigate the effectiveness and safety of pertussis component vaccines in adolesc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Jiawei, Liu, Shudan, Liu, Qin, Rong, Rong, Tang, Wenge, Wang, Qing, Kuang, Shanshan, Zhou, Chunbei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494346/ https://www.ncbi.nlm.nih.gov/pubmed/31008974 http://dx.doi.org/10.1097/MD.0000000000015281

Ejemplares similares

Immunogenicity of sequential poliovirus vaccination schedules with different strains of poliomyelitis vaccines in Chongqing, China: a cross-sectional survey
por: Xu, Jiawei, et al.
Publicado: (2021)

The Effect of Maternal Pertussis Immunization on Infant Vaccine Responses to a Booster Pertussis-Containing Vaccine in Vietnam
por: Maertens, Kirsten, et al.
Publicado: (2016)

Sero-survey of polio antibodies and quality of acute flaccid paralysis surveillance in Chongqing, China: A cross-sectional study
por: Xu, Jiawei, et al.
Publicado: (2020)

Prior exposure to B. pertussis shapes the mucosal antibody response to acellular pertussis booster vaccination
por: van Schuppen, Evi, et al.
Publicado: (2022)

Severe pertussis in a young infant due to household transmission: the needs of pertussis vaccination boosters in Japan
por: Takajo, Daiji, et al.
Publicado: (2018)

Long-Term Immunogenicity upon Pertussis Booster Vaccination in Young Adults and Children in Relation to Priming Vaccinations in Infancy
por: Versteegen, Pauline, et al.
Publicado: (2022)

Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: A collaborative study in Finland, the Netherlands, and the United Kingdom
por: Versteegen, Pauline, et al.
Publicado: (2021)

Age and Primary Vaccination Background Influence the Plasma Cell Response to Pertussis Booster Vaccination
por: Diks, Annieck M., et al.
Publicado: (2022)

Robust Humoral and Cellular Immune Responses to Pertussis in Adults After a First Acellular Booster Vaccination
por: van der Lee, Saskia, et al.
Publicado: (2018)

Corrigendum to ‘Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: A collaborative study in Finland, the Netherlands, and the United Kingdom’
por: Versteegen, Pauline, et al.
Publicado: (2021)

Underreporting of the 5-year tetanus, diphtheria, pertussis and polio booster vaccination in the Danish Vaccination Register
por: Voss, Sidsel Skou, et al.
Publicado: (2020)

A system-view of Bordetella pertussis booster vaccine responses in adults primed with whole-cell versus acellular vaccine in infancy
por: da Silva Antunes, Ricardo, et al.
Publicado: (2021)

Investigation of a pertussis outbreak and comparison of two acellular booster pertussis vaccines in a junior school in South East England, 2019
por: Tessier, Elise, et al.
Publicado: (2021)

A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in pregnant women
por: Puthanakit, Thanyawee, et al.
Publicado: (2023)

Cross-sectional seroprevalence study of antibody to Bordetella pertussis toxin in western Saudi Arabia: is there a need for a vaccine booster dose for adolescents and young adults?
por: Farahat, Fayssal, et al.
Publicado: (2021)

A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in women of childbearing age
por: Chokephaibulkit, Kulkanya, et al.
Publicado: (2022)

Acellular Pertussis Booster in Adolescents Induces Th1 and Memory CD8(+) T Cell Immune Response
por: Rieber, Nikolaus, et al.
Publicado: (2011)

Comparison of Safety of Different Vaccine Boosters Following Two-Dose Inactivated Vaccines: A Parallel Controlled Prospective Study
por: Lin, Zhi-Qiang, et al.
Publicado: (2022)

A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster vaccines in adults
por: Leroux-Roels, Geert, et al.
Publicado: (2017)

Pertussis Seroprevalence in Korean Adolescents and Adults Using Anti-Pertussis Toxin Immunoglobulin G
por: Lee, Soo Young, et al.
Publicado: (2014)

In Search of Factors Negatively Affecting Vaccine Immunity to Pertussis in Preschool Children before the Administration of the First Booster
por: Bednarek, Anna, et al.
Publicado: (2018)

Memory B Cell Activation Induced by Pertussis Booster Vaccination in Four Age Groups of Three Countries
por: Versteegen, Pauline, et al.
Publicado: (2022)

Strategies and safety considerations of booster vaccination in COVID-19
por: Meng, Hanyan, et al.
Publicado: (2022)

Seroprevalence Study of Pertussis in Adults at Childbearing Age and Young Infants Reveals the Necessity of Booster Immunizations in Adults in China
por: Chen, Zhiyun, et al.
Publicado: (2022)

Vaccination and Pertussis
por: Fink, Lawrence G.
Publicado: (1908)

Antibody persistence 2 and 3 years after booster vaccination of adolescents with recombinant acellular pertussis monovalent aP(gen) or combined TdaP(gen) vaccines
por: Pitisuttithum, Punnee, et al.
Publicado: (2021)

Economic evaluation of adolescents and adults’ pertussis vaccination: A systematic review of current strategies
por: Fernandes, Eder Gatti, et al.
Publicado: (2018)

Experts’ Opinion for Improving Pertussis Vaccination Rates in Adolescents and Adults: A Call to Action
por: Gabutti, Giovanni, et al.
Publicado: (2022)

Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after a first booster in adolescence: An open, phase III, non-randomized, multi-center study
por: Kovac, Martina, et al.
Publicado: (2018)

Report of a pertussis outbreak in a low coverage booster vaccination group of otherwise healthy children in Italy
por: Tafuri, Silvio, et al.
Publicado: (2013)

Pertussis Prevalence in Korean Adolescents and Adults with Persistent Cough
por: Lee, Soo Young, et al.
Publicado: (2015)

Comparison of the Effectiveness and Safety of Heterologous Booster Doses with Homologous Booster Doses for SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis
por: Deng, Jie, et al.
Publicado: (2022)

Acellular Pertussis Vaccines and Pertussis Resurgence: Revise or Replace?
por: Ausiello, Clara Maria, et al.
Publicado: (2014)

Pertussis Toxin: A Key Component in Pertussis Vaccines?
por: Gregg, Kelsey A., et al.
Publicado: (2019)

The effect of maternal pertussis vaccination on the epidemiology of pertussis in Spain
por: Godoy, Pere, et al.
Publicado: (2022)

The effect of maternal pertussis vaccination on the epidemiology of pertussis in Spain
por: Godoy, Pere, et al.
Publicado: (2022)

Safety of pertussis vaccination in pregnant women in UK: observational study
por: Donegan, Katherine, et al.
Publicado: (2014)

Antibody Specificity Following a Recent Bordetella pertussis Infection in Adolescence Is Correlated With the Pertussis Vaccine Received in Childhood
por: Raeven, René H. M., et al.
Publicado: (2019)

Pertussis toxin neutralizing antibody response after an acellular booster vaccination in Dutch and Finnish participants of different age groups
por: Knuutila, Aapo, et al.
Publicado: (2022)

Effectiveness of COVID-19 Vaccine Booster Shot Compared with Non-Booster: A Meta-Analysis
por: Zhu, Yajuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_07v6973j0ee2ntch6sspa3sbru